DAFTAR PUSTAKA
Aditama, T.Y., 2003. Fixed Dose Combination for TB Treatment. Med J Indones Vol. 12 No. 2. Arbex,
M.A.,
Varella,
M.C.L.,
Siqueira,
H.R.,
Mello,
F.A.F.,
2010.
Antituberculosis drugs: Drug interactions, adverse effects, and use in special situations Part 1: First line drugs. J Bras Pneumol;36(5):626640. American Thoracic Society: Diagnostic Standards and Classification of Tuberculosis in Adults and Children, 2000. Am J Respir Crit Care Med Vol 161. available at www.atsjournals.org American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: Treatment of Tuberculosis, 2003. Am J Respir Crit Care Med Vol 167. pp. 619-22. available at www.atsjournals.org Amin, Z., Bahar, A., 2009. Tuberkulosis Paru. Pada: Buku Ajar Ilmu Penyakit Dalam, jilid III edisi V, Sudoyo WA, editor. Jakarta: Interna Publishing, pp. 2230-8. Apriani, R.M., Fasich, Athijah, U., 2010. Analisis Terhadap Faktor-Faktor yang Mempengaruhi Kepatuhan Penggunaan Obat Anti Tuberkulosis Empat FDC (Fixed Dose Combination). Majalah Farmasi Airlangga, 8(1). Barmawi. 2004. Tuberkulosis: Ancaman Kegawatan Dunia Aspek Imunologi dan Terapi. Pidato Pengukuhan Jabatan Guru Besar pada Fakultas Kedokteran Universitas Gadjah Mada. Bartacek, A., Schutt, D., Panosch, B., Borek, M., 2009. Comparison of A FourDrug Fixed-Dose Combination Regimen with A Single Tablet Regimen in Smear Positive Pulmonary Tuberculosis. Int J Tuberc Lung Dis 13(6):760-6.
39
40
Brooks, G.F., Carroll, K.C., Butel, J.S., Morse, S.A., 2007. Mycobacteria. In: Medical Microbiology. 24th ed. United States of America: The McGraw-Hill Companies Inc, pp. 320-7. Burhan, E., 2010. Tuberkulosis Multi Drug Resistance (TB-MDR). Maj Kedokt Indon, vol 60. Chen, Y.C., Weezenbeek, C.V., Mori, T., Enarson, D.A., 2013. Challenges to the global control of tuberculosis. Asian Pacific Society of Respirology. Chuluq, A.C., Abijoso, Sidharta, B., 2004. Pengembangan Paket Obat SOT (Sediaan
Obat
Tunggal)
Untuk
Pengobatan
Tuberkulosa.
Bul.Penel.Kesehatan Vol.32, 127-134. Clinical Practice Guideline: Management of Tuberculosis (3rd edition). 2012. Malaysian Thoracic Society Data Penderita Tuberkulosis di Balai Besar Kesehatan Paru Masyarakat (BBKPM) Surakarta. 2012. Depkes RI (2009). Laporan Subdit TB Depkes RI, 2000-2010 (Tw-1). Jakarta. Depkes RI (2006). Pedoman Nasional Penanggulangan Tuberkulosis Edisi 2 Cetakan Pertama. Jakarta Dinkes Jateng. 2011. Profil Kesehatan Provinsi Jawa Tengah tahun 2011. Jawa Tengah Gitawati, R., 2008. Interaksi Obat dan Beberapa Implikasinya. Media Litbang Kesehatan Vol. XVIII No. 4. Hasan, H., 2010. Tuberkulosis Paru. Pada: Buku Ajar Ilmu Penyakit Paru 2010, Wibisono MJ, editor. Surabaya: Departemen Ilmu Penyakit Paru FK Unair – RSUD Dr. Soetomo, pp. 9-25. Herman, N., Aditama, T.Y., Ikhsan, M., 2008. Perbandingan Hasil Akhir Pengobatan Obat Antituberkulosis Kombinasi Dosis Tetap (KDT) dengan Kombipak pada Pengobatan Tuberkulosis Paru dengan Strategi DOTS di Puskesmas Kecamatan Jatinegara, Pulogadung dan Matraman Jakarta Timur. J Respir Indo Vol. 28.
41
Hertiyana, R., Rohani, Andrini, F., 2013. Karakteristik Pasien Tuberkulosis Paru Kasus Baru Dengan BTA Positif di RSUD Arifin Achmad Periode Januari 2009 sampai Desember 2012. International Standars for Tuberculosis Care : Diagnosis, Treatment and Public Care. (2006). Istiantoro, Y.H., Setiabudy, R., 2011. Tuberkulostatik dan Leprostatik. Pada: Farmakologi dan Terapi, edisi 5 cetak ulang dengan tambahan 2011, Gunawan SG, editor. Jakarta: Badan Penerbit FKUI, pp. 613-32. Jordao, L., Vieira, O.V., 2011. Review Article Tuberculosis: New Aspects of an Old Disease.Int Journal of Cell Biology, Volume 2011. Julita, I., 2012. Aspek Farmakokinetik Klinik beberapa Obat Berpotensi Hepatotoksik pada pasien Rawat Inap di Bangsal Paru RSUP Dr.M.Djamil Padang Periode Oktober 2011-Januari 2012. Kenyorini, Suradi, Surjanto, E., 2006. Uji Tuberkulin. Jurnal Tuberkulosis Indonesia, volume 3 no 2. Knechel, N.A., Tuberculosis: Pathophysiologi, Clinical Features, and Diagnosis. Crit Care Nurse.2009;29:34-43. Kurniati, I., 2010. Angka Konversi Penderita Tuberkulosis Paru yang Diobati dengan Obat Antituberkulosis (OAT) Paket Kategori Satu di BP4 Garut. MKB, Volume 42 No. 1. Lienhardt, C., Cook, S.V., Burgos, M., Edwards, V.Y., Rigouts, L., Anyo, G., 2011. Efficacy and Safety of a 4-Drug Fixed-Dose Combination Regimen Compared With Separate Drugs for Treatment of Pulmonary Tuberculosis The Study C Randomized Controlled Trial. JAMA. 2011;305(14):1415-1423.
Downloaded
From:
http://jama.jamanetwork.com/ on 05/20/2013 KMK RI Nomor 364/MENKES/SK/V/2009 tentang Pedoman Penanggulangan Tuberkulosis (TB) Mathew, J.L., 2009. Fixed-Dose Drug Combination for Treatment of Tuberculosis. Indian Pediatrics volume 46.
42
Monedero, I., Caminero, J.A., 2011. Evidence for promoting fixed-dose combination drugs in tuberculosis treatment and control: a review. Int J Tuberc Lung Dis 15(4):433–439. Nathanson, E., Nunn, P., Uplekar, M., Floyd, K., Jaramillo, E., Lonnroth, K., et al. 2010. MDR Tuberculosis—Critical Steps for Prevention and Control. N Eng J Med 363;11. Notoatmodjo, S., 2010. Metodologi Penelitian Kesehatan. Jakarta: Rineka Cipta, pp. 124-5 Nugroho, H., 2005. Penilaian Keberhasilan Pengobatan TB Paru Kombinasi Dosis Tetap di Surakarta. Tesis. Perhimpunan Dokter Paru Indonesia (PDPI). 2006. Pedoman Diagnosis dan Penatalaksanaan Tuberkulosis di Indonesia. Potter, B., Rindfleisch, K., Kraus.C.K., 2005. Management of Active Tuberculosis. American Family Physician Volume 72. available at www.aafp.org/afp Rasmin, M., Yunus, F., ZS, Priyanti., Melintira, I., Puspitorini, D., Rahayu, S., dkk. 2005. Profil Penderita Tuberkulosis Paru di Poli Paru RS Persahabatan Jnuari – Juli 2005. Jurnal Respirologi Indonesia. Retnoningrum, D.S., Kembaren, R.F., 2004. Mekanisme Tingkat Molekul Resistensi terhadap Beberapa Obat pada Mycobacterium Tuberkulosis. Acta Pharmaceutica Indonesia, volume XXIX No.3. Sastroasmoro, S., 2008. Dasar-dasar Metodologi Penelitian Klinis. Jakarta: Sagung Seto, pp. 127-146 Soetikno, R.D., Derry. 2011. Kesesuaian antara Foto Toraks dan Mikroskopis Sputum pada Evaluasi Respons Pengobatan Tuberkulosis Paru setelah Enam Bulan Pengobatan. MKB, Volume 43 No. 3. Sivasampu, S., 2006. Fixed Dose Combination (FDC) Drugs For Tuberculosis (TB) Treatment. Health Technology Assessment Unit Medical Development Division Ministry Of Health. Malaysia.
43
Surjanto, E., Subagio, Y., Reviono, Harsini, Marsabessy, Q.L., 2012. Profil Pasien Koinfeksi Tuberkulosis - HIV di RS Moewardi Surakarta 2010-2011. J Respir Indo Vol. 32, No. 2. Sutoyo, D.K., 2010. Multi Drug Resistance (MDR) Tuberkulosis. J Respir Indo Vol. 30, No. 2 J Respir Indo Vol. 30, No. 2, April 2010 Tabrani, I., 2007. Konversi Sputum BTA pada Fase Intensif TB Paru Kategori I antara Kombinasi Dosis Tetap (KDT) dan Obat Anti Tuberkulosis (OAT) Generik di RSUP. H. Adam Malik Medan. Tesis. WHO Operational Guide for National Tuberculosis Control Program On The Introduction and Use of fixed Dose Combination Drugs. (2002). available at www.who.org WHO Treatment of Tuberculosis Guidelines fourth edition. (2009). available at www.who.org WHO Global Tuberculosis Report. (2012). available at www.who.org Zulaikhah, S.T., Turijan. 2010. Pemantauan Efektivitas Obat Anti Tuberkulosis berdasarkan Pemeriksaan Sputum pada Penderita Tuberkulosis Paru. Jurnal Kesehatan Vol. 3 No. 1. Zumla, A., Raviglione, M., Hafner, R., Reyn, F.V., 2013. Current Concepts Tuberculosis. N Eng J Med 368;8.
